Company page
Vistagen Therapeutics, Inc.
Vistagen Therapeutics, Inc. is a public company traded under the ticker VTGN on the American market. The company has a market capitalization of approximately $22.8 million. Vistagen focuses on developing treatments for anxiety, depression, and other central nervous system disorders.
- Ticker
- VTGN:NASDAQ
- Asset type
- Stock
- Market cap
- $22.8M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD